CymitQuimica logo

CAS 1776112-90-3

:

N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide

Description:
N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide is a complex organic compound characterized by its unique structural features, including a pyrrolidine ring, a purine derivative, and a methoxy-substituted pyrazole. The presence of a fluorine atom in the structure contributes to its potential biological activity, possibly influencing its interaction with biological targets. This compound is likely to exhibit specific pharmacological properties, making it of interest in medicinal chemistry and drug development. Its molecular structure suggests potential applications in areas such as cancer therapy or other diseases where purine metabolism plays a role. The acrylamide functional group may also indicate reactivity that could be exploited in further chemical modifications or conjugations. Overall, the compound's intricate design reflects a balance between structural complexity and potential therapeutic utility, warranting further investigation into its biological effects and mechanisms of action.
Formula:C18H22FN9O2
Synonyms:
  • 2-Propenamide, N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-methyl-9H-purin-2-yl]-3-pyrrolidinyl]-
  • Mavelertinib( PF-06747775)
  • MAVELERTINIB
  • N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide
  • PF 6747775
  • PF-06747775
  • CPI-637
  • N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • CymitQuimica logo
    Apollo Scientific
    + Info

    Mavelertinib

    CAS:
    Mavelertinib
    Purity:≥98%
    Molecular weight:415.42g/mol

    Ref: 54-BUP21346

    1mg
    94.00€
    5mg
    206.00€
    10mg
    298.00€
  • Mavelertinib
    Targetmol
    + Info

    Mavelertinib

    CAS:
    <p>Mavelertinib (PF-06747775) is an EGFR tyrosine kinase (EGFR TKI) inhibitor that inhibits T790M/L858R and can be used to study tumours.</p>
    Formula:C18H22FN9O2
    Purity:99.89%
    Color and Shape:Solid
    Molecular weight:415.42

    Ref: TM-T21322

  • PF 06747775
    Biosynth
    + Info

    PF 06747775

    CAS:
    <p>PF 06747775 is a growth factor that binds to the epidermal growth factor receptor (EGFR) and toll-like receptor 4 (TLR4), thereby inhibiting their downstream signaling. PF 06747775 has been shown to be effective in treating cancer, inflammatory diseases, and other diseases characterized by uncontrolled cell proliferation. It also inhibits the activity of CDK4/6, which regulates the G0/G1 phase transition in cells. PF 06747775 is administered systemically as a microsphere formulation for oral delivery. The drug is currently in Phase II clinical trials for its potential use as a treatment for cancer and inflammatory diseases.</p>
    Formula:C18H22FN9O2
    Purity:Min. 95%
    Molecular weight:415.4 g/mol

    Ref: 3D-BWC11290

    50mg
    1,036.00€